Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Clinical Therapeutics|September 1, 1993
Effect of pharmaceutical formulation for diltiazem on health care expenditures for hypertensionT L Skaer, D A Sclar, L M Robison, et al.
Clinical Therapeutics|May 1, 1994
Ipratropium bromide in the management of chronic obstructive pulmonary disease: effect on health service expendituresD A Sclar, R F Legg, T L Skaer, et al.
Therapeutic Drug Monitoring|April 1, 1992
Pharmacokinetic population parameters for aminoglycosides in cholecystitis patientsM A Gill, M P Okamoto, R K Nakahiro, et al.
Clinical Therapeutics|May 1, 1991
Effectiveness of the C Cap in promoting prescription refill compliance among patients with glaucomaD A Sclar, T L Skaer, A Chin, et al.
Clinical Therapeutics|July 1, 1991
Effect of health education in promoting prescription refill compliance among patients with hypertensionD A Sclar, A Chin, T L Skaer, et al.
The Journal of Clinical Psychiatry|April 29, 1998
Economic outcomes with antidepressant pharmacotherapy: a retrospective intent-to-treat analysisD A Sclar, T L Skaer, L M Robison, et al.
Clinical Drug Investigation|March 29, 2008
Antidepressant prescribing patterns: a comparison of blacks and whites in a medicaid populationD A Sclar, L M Robison, T L Skaer, et al.
The Journal of Clinical Psychiatry|June 1, 1990
The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid populationJ S McCombs, M B Nichol, G L Stimmel, et al.
Clinical Therapeutics|July 1, 1993
Effect of pharmaceutical formulation for antihypertensive therapy on health service utilizationT L Skaer, D A Sclar, L M Robison, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|December 1, 1993
Effect of antihypertensive formulation on health service expendituresD A Sclar, T L Skaer, L M Robison, et al.
Pageof 5